Essential medicines and health products

An innovative approach to prevent corruption in the pharmaceutical sector

WHO Good Governance for Medicines programme, World Health Report (2010) Background Paper, No 25

Guitelle Baghdadi-Sabeti and Fatima Serhan

Publication details

Number of pages: 27
Publication date: 2010
Languages: English


This paper is intended to share country experiences in implementing the GGM programme in the last six years. It is based on information received from countries that have already implemented the GGM and have documented their experiences. A brief description of activities undertaken in these countries is presented below, focusing mainly on interventions at the country level that have led to changes and improvements in the pharmaceutical sector.

This paper also offers a number of analyses on "best practices" and "lessons learnt" with a view to inspiring health professionals, managers and policy makers in other countries in their efforts to strengthen health and pharmaceutical systems, as well as to reach universal health coverage and increase access to quality essential medicines. It is hoped also that this paper will serve as a contribution to move forward the international anti-corruption agenda within the pharmaceutical sector and beyond.